Evidence map›Paper›PMID 30008848›Full record

ArticleOncology letters2018

The dog as an animal model for bladder and urethral urothelial carcinoma: Comparative epidemiology and histology.

Simone de Brot, Brian D Robinson, Tim Scase, Llorenç Grau-Roma, Eleanor Wilkinson, Stephen A Boorjian, David Gardner, Nigel P Mongan

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Bioprinted research models of urological malignancy.Exploration (Beijing, China) · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Chronic Use of Deslorelin in Dogs: Six Cases (2005-2022).Animals : an open access journal from MDPI · 2023
    Article
  14. Article
  15. High intensity focused ultrasound for the treatment of solid tumors: a pilot study in canine cancer patients.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2022
    Article
  16. Article
  17. Review
  18. Desexing Dogs: A Review of the Current Literature.Animals : an open access journal from MDPI · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Simone de BrotSchool of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, LE12 5RD, UK.
Brian D RobinsonDepartment of Pathology, Weill Cornell Medical College, New York, NY 10065, USA.
Tim ScaseBridge Pathology Ltd., Bristol, BS7 0BJ, UK.
Llorenç Grau-RomaSchool of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, LE12 5RD, UK.
Eleanor WilkinsonSchool of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, LE12 5RD, UK.
Stephen A BoorjianDepartment of Urology, Mayo Clinic, Rochester, MN 55905, USA.
David GardnerSchool of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, LE12 5RD, UK.
Nigel P MonganSchool of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, LE12 5RD, UK.
University of Nottingham · GBCornell University · USMayo Clinic in Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the recent approval of several novel agents for patients with metastatic urothelial carcinoma (UC), survival in this setting remains poor. As such, continued investigation into novel therapeutic options remains warranted. Pre-clinical development of novel treatments requires an animal model that accurately simulates the disease in humans. The aim of the present study was to evaluate the dog as an animal model for human UC. A total of 260 cases of spontaneous, untreated canine primary urethral and urinary bladder UC, were epidemiologically and histologically assessed and classified based on the current 2016 World Health Organization (WHO) tumor classification system. Canine data was compared with human data available from scientific literature. The mean age of dogs diagnosed with UC was 10.22 years (range, 4-15 years), which is equivalent to 60-70 human years. The results revealed a high association between UC diagnosis with the female sex [odds ratio (OR) 3.51; 95% confidence interval (CI) 2.57-4.79; P<0.001], surgical neutering (OR 4.57; 95% CI 1.87-11.12; P<0.001) and breed (OR 15.11 for Scottish terriers; 95% CI 8.99-25.41; P<0.001). Based on the 2016 WHO tumor (T), node and metastasis staging system, the primary tumors were characterized as T1 (38%), T2a (28%), T2b (13%) and T3 (22%). Non-papillary, flat subgross tumor growth was strongly associated with muscle invasion (OR 31.00; P<0.001). Irrespective of subgross growth pattern, all assessable tumors were invading beyond the basement membrane compatible with infiltrating UC. Conventional, not further classifiable infiltrating UC was the most common type of tumor (90%), followed by UC with divergent, squamous and/or glandular differentiation (6%). Seven out of the 260 (2.8%) cases were classified as non-urothelial based on their histological morphology. These cases included 5 (2%) squamous cell carcinomas, 1 (0.4%) adenocarcinoma and 1 (0.4%) neuroendocrine tumor. The 2 most striking common features of canine and human UC included high sex predilection and histological tumor appearance. The results support the suitability of the dog as an animal model for UC and confirm that dogs also spontaneously develop rare UC subtypes and bladder tumors, including plasmacytoid UC and neuroendocrine tumor, which are herein described for the first time in a non-experimental animal species.

Indexed as

animal modelbladderdogurethraurothelial carcinoma

Identifiers

PMID30008848
PMCPMC6036476
OpenAlexW2800720514

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.